nab-paclitaxel combined with carboplatin
IRB-20230058-R
Phase 3 small_molecule active
Quick answer
nab-paclitaxel combined with carboplatin for Epithelial Ovarian Carcinoma Stage III is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Epithelial Ovarian Carcinoma Stage III
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active